Parasympathetic nervous system in nocturnal asthma
- PMID: 3132275
- PMCID: PMC2545890
- DOI: 10.1136/bmj.296.6634.1427
Parasympathetic nervous system in nocturnal asthma
Abstract
To investigate the effect of vagal blockade with atropine on nocturnal fall in peak expiratory flow rate 10 patients with asthma who had a diurnal variation in peak expiratory flow rate of greater than 20% were given 30 micrograms/kg of intravenous atropine or a placebo at 4 am and 4 pm. Vagal blockade caused significant bronchodilatation at 4 am and 4 pm (peak expiratory flow rate rose from 260 to 390 l/min at 4 am and 400 to 440 l/min at 4 pm) and significantly increased the pulse rate from 60 to 121 beats/minute at 4 am and from 76 to 122 beats/minute at 4 pm. Nocturnal asthma was almost totally reversed, implying that vagal mechanisms are fundamental in its pathophysiology. Other mechanisms--diurnal changes in plasma adrenaline concentration, the activity of non-adrenergic non-cholinergic nerves, and circadian rhythms of inflammatory mediator activity--may also be implicated.
Similar articles
-
Adrenaline and nocturnal asthma.BMJ. 1990 Sep 8;301(6750):473-6. doi: 10.1136/bmj.301.6750.473. BMJ. 1990. PMID: 2207401 Free PMC article. Clinical Trial.
-
The effect of the circadian rhythm of vagal activity on bronchomotor tone in asthma.Br J Clin Pharmacol. 1989 Nov;28(5):545-9. doi: 10.1111/j.1365-2125.1989.tb03540.x. Br J Clin Pharmacol. 1989. PMID: 2531606 Free PMC article. Clinical Trial.
-
Non-adrenergic, non-cholinergic function in the human airway.Respir Med. 1998 Mar;92(3):461-6. doi: 10.1016/s0954-6111(98)90292-x. Respir Med. 1998. PMID: 9692106 Clinical Trial.
-
Nocturnal asthma: circadian rhythms and therapeutic interventions.Am Rev Respir Dis. 1993 Jun;147(6 Pt 2):S25-8. doi: 10.1164/ajrccm/147.6_Pt_2.S25. Am Rev Respir Dis. 1993. PMID: 8494197 Review.
-
[Nocturnal asthma].Rev Med Chir Soc Med Nat Iasi. 2006 Jul-Sep;110(3):505-10. Rev Med Chir Soc Med Nat Iasi. 2006. PMID: 17571537 Review. Romanian.
Cited by
-
Muscarinic receptor subtypes: implications for lung disease.Thorax. 1989 Mar;44(3):161-7. doi: 10.1136/thx.44.3.161. Thorax. 1989. PMID: 2650010 Free PMC article. Review. No abstract available.
-
Effects of H1-receptor blockade with terfenadine in nocturnal asthma.Br J Clin Pharmacol. 1991 Sep;32(3):371-3. doi: 10.1111/j.1365-2125.1991.tb03914.x. Br J Clin Pharmacol. 1991. PMID: 1777375 Free PMC article. Clinical Trial.
-
Involvement of central 5-HT1A receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats.Br J Pharmacol. 1996 Feb;117(4):724-8. doi: 10.1111/j.1476-5381.1996.tb15250.x. Br J Pharmacol. 1996. PMID: 8646420 Free PMC article.
-
A study on pulmonary function in children with obstructive sleep apnea hypopnea syndrome.Sleep Breath. 2024 Aug;28(4):1793-1798. doi: 10.1007/s11325-024-03043-y. Epub 2024 May 8. Sleep Breath. 2024. PMID: 38717718 Free PMC article.
-
Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study.Postgrad Med J. 1994 May;70(823):350-4. doi: 10.1136/pgmj.70.823.350. Postgrad Med J. 1994. PMID: 8016006 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical